sorafenib has been researched along with pyruvic acid in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (pyruvic acid) | Trials (pyruvic acid) | Recent Studies (post-2010) (pyruvic acid) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 8,310 | 169 | 2,501 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gnocchi, D; Kurzyk, A; Lentini, G; Mazzocca, A; Mintrone, A; SabbĂ , C | 1 |
1 other study(ies) available for sorafenib and pyruvic acid
Article | Year |
---|---|
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Glycolysis; Humans; Lactic Acid; Liver Neoplasms; Oxidative Phosphorylation; Pyruvic Acid; Receptors, Lysophosphatidic Acid; Sorafenib | 2022 |